Xcell Therapeutics Revenue

In the year 2025, Xcell Therapeutics had annual revenue of 1.95B KRW with 0.76% growth. Xcell Therapeutics had revenue of 1.06B in the quarter ending December 31, 2025, with 123.15% growth.

Revenue

1.95B

Revenue Growth

+0.76%

P/S Ratio

15.73

Revenue / Employee

n/a

Employees

n/a

Market Cap

30.66B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	1.95B	14.65M	0.76%
Dec 31, 2024	1.93B	810.45M	72.11%
Dec 31, 2023	1.12B	103.86M	10.18%
Dec 31, 2022	1.02B	-946.25M	-48.12%
Dec 31, 2021	1.97B	1.43B	264.00%
Dec 31, 2020	Pro	Pro	Pro
Dec 31, 2019	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
ORIENT BIO	59.09B
GeneOne Life Science	23.04B
CG Invites	27.39B
IMB Dx	5.33B
Oncocross	370.46M
iNtRON Biotechnology	5.74B
Amicogen	41.98B
ENCell	5.26B

Revenue Rankings